17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions

Autores
Gambino, Y.P.; Maymó, J.L.; Pérez-Pérez, A.; Dueñas, J.L.; Sánchez-Margalet, V.; Calvo, J.C.; Varone, C.L.
Año de publicación
2010
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.
Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fuente
Biol. Reprod. 2010;83(1):42-51
Materia
17beta-estradiol
Gene expression
Leptin
MAPK signal transduction pathway
Placenta
2 (2 amino 3 methoxyphenyl)chromone
estradiol
estrogen receptor
estrogen receptor alpha
fulvestrant
leptin
luciferase
mitogen activated protein kinase
phosphatidylinositol 3 kinase
wortmannin
estradiol
estrogen receptor alpha
estrogen receptor alpha, human
fulvestrant
leptin
mitogen activated protein kinase
phosphatidylinositol 3 kinase
protein kinase B
adipocyte
article
cancer cell culture
choriocarcinoma
concentration response
controlled study
embryo
enzyme inhibition
enzyme phosphorylation
explant
gene deletion
gene expression
human
human cell
human tissue
nidation
placenta
plasmid
pregnancy
priority journal
promoter region
reporter gene
signal transduction
transient transfection
trophoblast
Western blotting
analogs and derivatives
antagonists and inhibitors
female
in vitro study
metabolism
placenta
signal transduction
tumor cell line
Bovinae
Cell Line, Tumor
Estradiol
Estrogen Receptor alpha
Extracellular Signal-Regulated MAP Kinases
Female
Humans
In Vitro Techniques
Leptin
MAP Kinase Signaling System
Phosphatidylinositol 3-Kinases
Placenta
Pregnancy
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt
Receptor Cross-Talk
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/2.5/ar
Repositorio
Biblioteca Digital (UBA-FCEN)
Institución
Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
OAI Identificador
paperaa:paper_00063363_v83_n1_p42_Gambino

id BDUBAFCEN_0a920b2cbf470c623b1b3f5402ef71a4
oai_identifier_str paperaa:paper_00063363_v83_n1_p42_Gambino
network_acronym_str BDUBAFCEN
repository_id_str 1896
network_name_str Biblioteca Digital (UBA-FCEN)
spelling 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actionsGambino, Y.P.Maymó, J.L.Pérez-Pérez, A.Dueñas, J.L.Sánchez-Margalet, V.Calvo, J.C.Varone, C.L.17beta-estradiolGene expressionLeptinMAPK signal transduction pathwayPlacenta2 (2 amino 3 methoxyphenyl)chromoneestradiolestrogen receptorestrogen receptor alphafulvestrantleptinluciferasemitogen activated protein kinasephosphatidylinositol 3 kinasewortmanninestradiolestrogen receptor alphaestrogen receptor alpha, humanfulvestrantleptinmitogen activated protein kinasephosphatidylinositol 3 kinaseprotein kinase Badipocytearticlecancer cell culturechoriocarcinomaconcentration responsecontrolled studyembryoenzyme inhibitionenzyme phosphorylationexplantgene deletiongene expressionhumanhuman cellhuman tissuenidationplacentaplasmidpregnancypriority journalpromoter regionreporter genesignal transductiontransient transfectiontrophoblastWestern blottinganalogs and derivativesantagonists and inhibitorsfemalein vitro studymetabolismplacentasignal transductiontumor cell lineBovinaeCell Line, TumorEstradiolEstrogen Receptor alphaExtracellular Signal-Regulated MAP KinasesFemaleHumansIn Vitro TechniquesLeptinMAP Kinase Signaling SystemPhosphatidylinositol 3-KinasesPlacentaPregnancyPromoter Regions, GeneticProto-Oncogene Proteins c-aktReceptor Cross-TalkThe process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.2010info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_GambinoBiol. Reprod. 2010;83(1):42-51reponame:Biblioteca Digital (UBA-FCEN)instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesinstacron:UBA-FCENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/ar2025-09-04T09:48:37Zpaperaa:paper_00063363_v83_n1_p42_GambinoInstitucionalhttps://digital.bl.fcen.uba.ar/Universidad públicaNo correspondehttps://digital.bl.fcen.uba.ar/cgi-bin/oaiserver.cgiana@bl.fcen.uba.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:18962025-09-04 09:48:39.017Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesfalse
dc.title.none.fl_str_mv 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
title 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
spellingShingle 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
Gambino, Y.P.
17beta-estradiol
Gene expression
Leptin
MAPK signal transduction pathway
Placenta
2 (2 amino 3 methoxyphenyl)chromone
estradiol
estrogen receptor
estrogen receptor alpha
fulvestrant
leptin
luciferase
mitogen activated protein kinase
phosphatidylinositol 3 kinase
wortmannin
estradiol
estrogen receptor alpha
estrogen receptor alpha, human
fulvestrant
leptin
mitogen activated protein kinase
phosphatidylinositol 3 kinase
protein kinase B
adipocyte
article
cancer cell culture
choriocarcinoma
concentration response
controlled study
embryo
enzyme inhibition
enzyme phosphorylation
explant
gene deletion
gene expression
human
human cell
human tissue
nidation
placenta
plasmid
pregnancy
priority journal
promoter region
reporter gene
signal transduction
transient transfection
trophoblast
Western blotting
analogs and derivatives
antagonists and inhibitors
female
in vitro study
metabolism
placenta
signal transduction
tumor cell line
Bovinae
Cell Line, Tumor
Estradiol
Estrogen Receptor alpha
Extracellular Signal-Regulated MAP Kinases
Female
Humans
In Vitro Techniques
Leptin
MAP Kinase Signaling System
Phosphatidylinositol 3-Kinases
Placenta
Pregnancy
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt
Receptor Cross-Talk
title_short 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
title_full 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
title_fullStr 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
title_full_unstemmed 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
title_sort 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
dc.creator.none.fl_str_mv Gambino, Y.P.
Maymó, J.L.
Pérez-Pérez, A.
Dueñas, J.L.
Sánchez-Margalet, V.
Calvo, J.C.
Varone, C.L.
author Gambino, Y.P.
author_facet Gambino, Y.P.
Maymó, J.L.
Pérez-Pérez, A.
Dueñas, J.L.
Sánchez-Margalet, V.
Calvo, J.C.
Varone, C.L.
author_role author
author2 Maymó, J.L.
Pérez-Pérez, A.
Dueñas, J.L.
Sánchez-Margalet, V.
Calvo, J.C.
Varone, C.L.
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv 17beta-estradiol
Gene expression
Leptin
MAPK signal transduction pathway
Placenta
2 (2 amino 3 methoxyphenyl)chromone
estradiol
estrogen receptor
estrogen receptor alpha
fulvestrant
leptin
luciferase
mitogen activated protein kinase
phosphatidylinositol 3 kinase
wortmannin
estradiol
estrogen receptor alpha
estrogen receptor alpha, human
fulvestrant
leptin
mitogen activated protein kinase
phosphatidylinositol 3 kinase
protein kinase B
adipocyte
article
cancer cell culture
choriocarcinoma
concentration response
controlled study
embryo
enzyme inhibition
enzyme phosphorylation
explant
gene deletion
gene expression
human
human cell
human tissue
nidation
placenta
plasmid
pregnancy
priority journal
promoter region
reporter gene
signal transduction
transient transfection
trophoblast
Western blotting
analogs and derivatives
antagonists and inhibitors
female
in vitro study
metabolism
placenta
signal transduction
tumor cell line
Bovinae
Cell Line, Tumor
Estradiol
Estrogen Receptor alpha
Extracellular Signal-Regulated MAP Kinases
Female
Humans
In Vitro Techniques
Leptin
MAP Kinase Signaling System
Phosphatidylinositol 3-Kinases
Placenta
Pregnancy
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt
Receptor Cross-Talk
topic 17beta-estradiol
Gene expression
Leptin
MAPK signal transduction pathway
Placenta
2 (2 amino 3 methoxyphenyl)chromone
estradiol
estrogen receptor
estrogen receptor alpha
fulvestrant
leptin
luciferase
mitogen activated protein kinase
phosphatidylinositol 3 kinase
wortmannin
estradiol
estrogen receptor alpha
estrogen receptor alpha, human
fulvestrant
leptin
mitogen activated protein kinase
phosphatidylinositol 3 kinase
protein kinase B
adipocyte
article
cancer cell culture
choriocarcinoma
concentration response
controlled study
embryo
enzyme inhibition
enzyme phosphorylation
explant
gene deletion
gene expression
human
human cell
human tissue
nidation
placenta
plasmid
pregnancy
priority journal
promoter region
reporter gene
signal transduction
transient transfection
trophoblast
Western blotting
analogs and derivatives
antagonists and inhibitors
female
in vitro study
metabolism
placenta
signal transduction
tumor cell line
Bovinae
Cell Line, Tumor
Estradiol
Estrogen Receptor alpha
Extracellular Signal-Regulated MAP Kinases
Female
Humans
In Vitro Techniques
Leptin
MAP Kinase Signaling System
Phosphatidylinositol 3-Kinases
Placenta
Pregnancy
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt
Receptor Cross-Talk
dc.description.none.fl_txt_mv The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.
Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
description The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.
publishDate 2010
dc.date.none.fl_str_mv 2010
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_Gambino
url http://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_Gambino
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/2.5/ar
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/ar
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Biol. Reprod. 2010;83(1):42-51
reponame:Biblioteca Digital (UBA-FCEN)
instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
instacron:UBA-FCEN
reponame_str Biblioteca Digital (UBA-FCEN)
collection Biblioteca Digital (UBA-FCEN)
instname_str Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
instacron_str UBA-FCEN
institution UBA-FCEN
repository.name.fl_str_mv Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
repository.mail.fl_str_mv ana@bl.fcen.uba.ar
_version_ 1842340704913719296
score 12.623145